Toward the Optimization of (+)-[11C]PHNO Synthesis: Time Reduction and Process Validation

Contrast Media Mol Imaging. 2019 Sep 30:2019:4292596. doi: 10.1155/2019/4292596. eCollection 2019.

Abstract

(+)-[11C]PHNO, a dopamine D2/3 receptor agonistic radiotracer, is applied for investigating the dopaminergic system via positron emission tomography (PET). An improved understanding of neuropsychiatric disorders associated with dysfunctions in the dopamine system and the underlying mechanism is a necessity in order to promote the development of new potential therapeutic drugs. In contrast to other broadly applied 11C-radiopharmaceuticals, the production of this radiotracer requires a challenging four-step radiosynthesis involving harsh reaction conditions and reactants as well as an inert atmosphere. Consequently, the production is prone to errors and troubleshooting after failed radiosyntheses remains time consuming. Hence, we aimed to optimize the radiosynthesis of (+)-[11C]PHNO for achieving better activity yields without loss of product quality. Therefore, we synthesized (+)-[11C]PHNO and omitted all heating and cooling steps leading to higher activity yields. As a result, radiosynthesis fully conducted at room temperature led to a time-reduced production procedure that saves about 5 min, which is an appreciable decay-prevention of around 15% of the activity yield. Additionally, we established a troubleshooting protocol by investigating reaction intermediates, byproducts, and impurities. Indeed, partial runs enabled the assignment of byproducts to their associated error source. Finally, we were able to generate a decision tree facilitating error detection in (+)-[11C]PHNO radiosynthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / diagnostic imaging
  • Brain / diagnostic imaging*
  • Brain / pathology
  • Carbon Radioisotopes / chemistry
  • Carbon Radioisotopes / pharmacology*
  • Humans
  • Parkinson Disease / diagnostic imaging
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals / chemical synthesis*
  • Radiopharmaceuticals / chemistry
  • Radiopharmaceuticals / pharmacology
  • Receptors, Dopamine D2 / agonists
  • Receptors, Dopamine D2 / chemistry
  • Receptors, Dopamine D2 / isolation & purification*
  • Schizophrenia / diagnostic imaging

Substances

  • Carbon Radioisotopes
  • Radiopharmaceuticals
  • Receptors, Dopamine D2